Progressing Stage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Confirms Eligibility of XORLO™ for Accelerated Approval

FDA Confirms Eligibility of XORLO™ for Accelerated Approval
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

David melamedAllen davidoffNick rigopulosVenture exchangeTherapeutics incDrug administrationEuropean medicines agencyWall streetSpecial protocol assessmentOrphan drug designationPlacebo controlledRandomized withdrawal design studyNovel oxypurinol formulationProgressing stageSurrogate endpointsDrug approval

XORTX Therapeutics Inc (XRTX) Announces FDA Confirmed XORLO s Eligibility for Accelerated Approval

XORTX Therapeutics Inc (XRTX) Announces FDA Confirmed XORLO s Eligibility for Accelerated Approval
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Allen davidoffNick rigopulosDavid melamedEuropean medicines agencyVenture exchangeDrug administrationTherapeutics incSpecial protocol assessmentOrphan drug designationPlacebo controlledRandomized withdrawal design studyNovel oxypurinol formulationProgressing stageSurrogate endpointsDrug approval

XORTX Announces Type D Meeting with FDA to be held May 1,

● Type D Meeting Requested to Accelerate XRx-008 Clinical Program ● CALGARY, Alberta, March 14, 2023 (GLOBE NEWSWIRE) XORTX Therapeutics Inc..

Nick rigopulosAllen davidoffDavid melamedTherapeutics incEuropean medicines agencyDrug administrationVenture exchangeClinical programTyped meeting requestedPlacebo controlledRandomized withdrawal design studyNovel oxypurinol formulationProgressing stageSurrogate endpointsDrug approvalTsx venture exchange xrtx